HOME >> MEDICINE >> NEWS
Understanding how prostaglandin prevents gut injury during radiation therapy

People undergoing radiation therapy for diseases such as cancer run the risk of irreversibly damaging the cells of their intestine due to the radiation-induced death of cells within the gut. Previous studies have demonstrated that treatment of mice with protaglandin E2 (PGE2) is capable of inhibiting cell death in the intestine that occurs as a result of exposure to radiation.

In the December 1 issue of the Journal of Clinical Investigation, Teresa Tessner and colleagues from the Washington University School of Medicine pursued the mechanism by which PGE2 protects against radiation-induced injury in mice. They demonstrate that radiation-induced cell death can be dependent or independent of the bax protein, however the beneficial effect of PGE2 treatment is only achieved via a bax-dependent mechanism. Bax is normally expressed in the cell cytoplasm, however in response to radiation exposure, bax relocates to the mitochondrial membrane and trigger cell signaling events that lead to cell death. Administration of PGE2 to radiation-exposed mice was found to activate AKT phosphorylation events that block the relocation of bax within the cell, and therefore prevent cell death.

The data suggest that PGE2 or other drugs that increase AKP phosphorylation should reduce injury to the small intestine during radiation therapy. Conversely, cancers with mutations that inactivate bax and block its relocation to the mitochondria may be resistant to radiation therapy. This work may have significant clinical impact if the use of PGE2 could be shown to be effective for protection against radiation-induced gut injury in humans.


'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-0497
Journal of Clinical Investigation
1-Dec-2004


Page: 1

Related medicine news :

1. Understanding how vulnerabilities may keep women in abusive relationships
2. From town planning to intimate sex: Understanding the risks in our lives
3. Understanding epilepsy
4. The long view: Understanding why cancer strikes late
5. Understanding the autoimmune response in type 1 diabetes
6. Understanding nerve degeneration in spastic paraplegia
7. Understanding how lymph nodes respond to infection may redefine how immune system functions
8. Understanding Alzheimers disease: Animal research points to new direction for therapy
9. Understanding genetic cancer risk might not help smokers kick the habit
10. Understanding cancer patients needs, concerns, is key to improving clinical trial participation
11. Understanding Why Antibiotics May Be Over-prescribed For Patients With Sore Throats

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
Breaking Medicine Technology:
Cached News: